Hayes Christopher G.
Insider CIK 1805359 · VRCA General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRCA Verrica Pharmaceuticals In | S Sale | 2025-03-17 | 2025-03-18 | 4,315 | $0.65 | $2.8K | 176,458 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2025-03-14 | 2025-03-18 | 250,000 | — | $0 | 250,000 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2024-10-09 | 2024-10-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | S Sale | 2024-08-27 | 2024-08-28 | 9,530 | $2.46 | $23.4K | 105,773 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | S Sale | 2024-08-26 | 2024-08-28 | 26,183 | $2.66 | $69.6K | 115,303 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | S Sale | 2024-07-23 | 2024-07-23 | 91 | $6.98 | $635 | 141,486 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | S Sale | 2024-07-22 | 2024-07-23 | 21,649 | $7.06 | $152.8K | 141,577 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2024-03-15 | 2024-03-19 | 80,000 | — | $0 | 80,000 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award | 2024-03-15 | 2024-03-19 | 40,000 | — | $0 | 163,226 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | S Sale | 2023-11-15 | 2023-11-16 | 11,558 | $2.97 | $34.3K | 123,226 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | S Sale | 2023-11-14 | 2023-11-16 | 22,141 | $2.93 | $64.9K | 134,784 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award | 2023-08-24 | 2025-02-06 | 150,000 | — | $0 | 231,925 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award | 2023-08-24 | 2023-08-28 | 75,000 | — | $0 | 156,925 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | S Sale | 2023-07-24 | 2023-07-25 | 33,789 | $4.83 | $163.2K | 81,925 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award | 2023-07-21 | 2023-07-25 | 100,000 | — | $0 | 115,714 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2023-03-01 | 2023-03-03 | 135,000 | — | $0 | 135,000 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2022-07-11 | 2022-07-11 | 7,500 | $3.40 | $25.5K | 15,714 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2022-07-05 | 2022-07-05 | 5,714 | $2.10 | $12.0K | 8,214 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2022-02-24 | 2022-02-25 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2021-06-04 | 2021-06-07 | 2,500 | $9.79 | $24.5K | 2,500 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2021-03-01 | 2021-03-03 | 65,000 | — | $0 | 65,000 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2020-02-27 | 2020-03-03 | 55,000 | — | $0 | 55,000 | SEC↗ |